McKesson Corporation

MCK·NYSE
Compare
938.84+8.59 (+0.92%)today
At close: Oct 9, 4:00 PM EDT · Real-time · USD
After hours938.84+0.07 (+0.01%)Oct 9, 4:04 PM EDT

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close930.25
Open927.56
Day range925.00943.97
52-week range723.68999.00
Volume482.89K
Avg. volume (3M)917.88K
Market cap109.46B
P/E ratio (TTM)25.16
Forward P/E18.61
EPS (TTM)37.31
Dividend yield0.40% (3.76)
Beta (5Y)—
Shares outstanding116.59M
Earnings dateNov 4, 2026
Analyst target—
Profit margin—

Latest news

All MCK news ›
@MMMnews·

Rx Rundown: McKesson, Caribou Biosciences, Viatris and more

Check out this week’s medical marketing news, dealmaking and industry chatter. Clayton, Dubilier & Rice (CD&R) and McKesson acquired Option Care Health for $5.8 billion. Viatris said it will acquire Pacira Biosciences for $1.65 billion. GE…

The Globe and Mail·

McKesson, CD&R to Acquire Option Care Health

An announcement from McKesson ( (MCK) ) is now available. The most recent analyst rating on (MCK) stock is a Buy with a $977.00 price target. To see the full list of analyst forecasts on McKesson stock, see the MCK Stock Forecast page.…

@PRNewswire·

McKesson (MCK) Stock Trades Down, Here Is Why

Shares of healthcare distributor and services company McKesson (NYSE: MCK) fell 3.5% in the afternoon session after reports revealed that CEO, Brian S. Tyler, sold 8,463 shares of company stock. The sale, valued at approximately $6.7…

Yahoo Finance·

McKesson Corporation (MCK) Stock Forecasts

Yahoo Finance Oops, something went wrong McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains,…

From articles in the 4Search news index.

In the news

1,566mentions in 30 days
97with it in the headline
Mixedheadline tone

Measured across the 4ScienceFiction news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4ScienceFiction index. Terms of use.